6 results on '"Richard, Edo"'
Search Results
2. Experiences of dementia and attitude towards prevention: a qualitative study among older adults participating in a prevention trial.
- Author
-
Rosenberg, Anna, Coley, Nicola, Soulier, Alexandra, Kulmala, Jenni, Soininen, Hilkka, Andrieu, Sandrine, Kivipelto, Miia, Barbera, Mariagnese, for the MIND-AD and HATICE groups, Sindi, Shireen, Solomon, Alina, Richard, Edo, van Middelaar, Tessa, Hartmann, Tobias, Brayne, Carol, van Gool, Pim, Moll van Charante, Eric, Beishuizen, Cathrien, Jongstra, Susan, and van Wanrooij, Lennard
- Subjects
OLDER people ,PERCEPTUAL disorders ,DEMENTIA ,COGNITION disorders ,QUALITATIVE research - Abstract
Background: A better insight into older adults' understanding of and attitude towards cognitive disorders and their prevention, as well as expectations and reasons for participation in prevention trials, would help design, conduct, and implement effective preventive interventions. This qualitative study aimed at exploring the knowledge and perceptions of cognitive disorders and their prevention among participants in a prevention trial.Methods: Semi-structured interviews were conducted among the participants of a multinational randomised controlled trial testing the efficacy of a lifestyle-based eHealth intervention in preventing cardiovascular disease or cognitive decline in community dwellers aged 65+. Participants were probed on their reasons for participation in the trial and their views on general health, cardiovascular disease, ageing, and prevention. The subset of data focusing on cognitive disorders (15 interviewees; all in Finland) was considered for this study. Data were analysed using content analysis.Results: Participants' knowledge of the cause and risk factors of cognitive disorders and prevention was limited and superficial, and a need for up-to-date, reliable, and practical information and advice was expressed. Cognitive disorders evoked fear and concern, and feelings of hopelessness and misery were frequently expressed, indicating a stigma. Strong heredity of cognitive disorders was a commonly held belief, and opinions on the possibility of prevention were doubtful, particularly in relation to primary prevention. Family history and/or indirect experiences of cognitive disorders was a recurrent theme and it showed to be linked to both the knowledge of and feelings associated with cognitive disorders, as well as attitude towards prevention. Indirect experiences were linked to increased awareness and knowledge, but also uncertainty about risk factors and possibility of prevention. Distinct fear and concerns, particularly over one's own cognition/risk, and high motivation towards engaging in prevention and participating in a prevention trial were also identified in connection to this theme.Conclusions: Family history and/or indirect experiences of cognitive disorders were linked to sensitivity and receptiveness to brain health and prevention potential. Our findings may be helpful in addressing older adults' expectations in future prevention trials to improve recruitment, maximise adherence, and facilitate the successful implementation of interventions. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
3. Post-stroke dementia - a comprehensive review.
- Author
-
Mijajlović, Milija D., Pavlović, Aleksandra, Brainin, Michael, Heiss, Wolf-Dieter, Quinn, Terence J., Ihle-Hansen, Hege B., Hermann, Dirk M., Assayag, Einor Ben, Richard, Edo, Thiel, Alexander, Kliper, Efrat, Yong-Il Shin, Yun-Hee Kim, SeongHye Choi, San Jung, Yeong-Bae Lee, Sinanović, Osman, Levine, Deborah A., Schlesinger, Ilana, and Mead, Gillian
- Subjects
TREATMENT of dementia ,DEMENTIA patients ,BRAIN imaging ,GENETIC polymorphisms ,IMAGING of cerebral circulation ,COMPUTED tomography ,MAGNETIC resonance imaging ,POSITRON emission tomography ,DIAGNOSIS of dementia ,GERIATRIC assessment ,DEMENTIA ,PROGNOSIS ,PSYCHOLOGICAL tests ,QUESTIONNAIRES ,STROKE ,DISEASE complications - Abstract
Post-stroke dementia (PSD) or post-stroke cognitive impairment (PSCI) may affect up to one third of stroke survivors. Various definitions of PSCI and PSD have been described. We propose PSD as a label for any dementia following stroke in temporal relation. Various tools are available to screen and assess cognition, with few PSD-specific instruments. Choice will depend on purpose of assessment, with differing instruments needed for brief screening (e.g., Montreal Cognitive Assessment) or diagnostic formulation (e.g., NINDS VCI battery). A comprehensive evaluation should include assessment of pre-stroke cognition (e.g., using Informant Questionnaire for Cognitive Decline in the Elderly), mood (e.g., using Hospital Anxiety and Depression Scale), and functional consequences of cognitive impairments (e.g., using modified Rankin Scale). A large number of biomarkers for PSD, including indicators for genetic polymorphisms, biomarkers in the cerebrospinal fluid and in the serum, inflammatory mediators, and peripheral microRNA profiles have been proposed. Currently, no specific biomarkers have been proven to robustly discriminate vulnerable patients ('at risk brains') from those with better prognosis or to discriminate Alzheimer's disease dementia from PSD. Further, neuroimaging is an important diagnostic tool in PSD. The role of computerized tomography is limited to demonstrating type and location of the underlying primary lesion and indicating atrophy and severe white matter changes. Magnetic resonance imaging is the key neuroimaging modality and has high sensitivity and specificity for detecting pathological changes, including small vessel disease. Advanced multi-modal imaging includes diffusion tensor imaging for fiber tracking, by which changes in networks can be detected. Quantitative imaging of cerebral blood flow and metabolism by positron emission tomography can differentiate between vascular dementia and degenerative dementia and show the interaction between vascular and metabolic changes. Additionally, inflammatory changes after ischemia in the brain can be detected, which may play a role together with amyloid deposition in the development of PSD. Prevention of PSD can be achieved by prevention of stroke. As treatment strategies to inhibit the development and mitigate the course of PSD, lowering of blood pressure, statins, neuroprotective drugs, and anti-inflammatory agents have all been studied without convincing evidence of efficacy. Lifestyle interventions, physical activity, and cognitive training have been recently tested, but large controlled trials are still missing. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
4. Quality of life after surgical decompression for a space-occupying middle cerebral artery infarct: A cohort study.
- Author
-
van Middelaar, Tessa, Richard, Edo, van der Worp, H. Bart, van den Munckhof, Pepijn, Nieuwkerk, Pythia T., Visser, Marieke C., Stam, Jan, and Nederkoorn, Paul J.
- Subjects
- *
QUALITY of life , *SURGICAL decompression , *DECOMPRESSIVE craniectomy , *CEREBRAL arteries , *INFARCTION - Abstract
Background: In patients with a space-occupying middle cerebral artery (MCA) infarct surgical decompression reduces the risk of death, but increases the chance of survival with severe disability. We assessed quality of life (QoL), symptoms of depression, and caregiver burden at long-term follow-up. Methods: Patients treated in two academic centres between 2007 and 2012 were included. Follow-up was at least six months. Patients and caregivers were interviewed separately. QoL was assessed with a visual analogue scale and the 36-item Short-Form health survey (SF-36); depression with the Hospital Anxiety and Depression Scale; and caregiver burden with the Caregiver Strain Index. Results: Twenty five patients were enrolled, of whom seven had an infarct in the dominant hemisphere. After a median follow-up of 26 months (IQR 11-46) the median SF-36 mental component score was 54.4 (IQR 45-60), indicating a mental QoL comparable to that in the general population. The median SF-36 physical component score was 32.7 (IQR 22-38), indicating a worse physical QoL. Dominance of the hemisphere did not influence QoL. 79 % of patients and 65 % of caregivers would, in retrospect, again choose for surgery. 26 % of patients had signs of depression and 64 % of caregivers were substantially burdened in their daily life. Conclusions: Mental QoL after surgical decompression for space-occupying MCA infarct is comparable to that in the general population, whereas physical QoL is worse. Dominance of the hemisphere did not influence QoL. The majority of caregivers experience substantial burden. Most patients and caregivers stand by their decision for hemicraniectomy. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
5. The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results.
- Author
-
Aalten, Pauline, Ramakers, Inez H. G. B., Biessels, Geert Jan, de Deyn, Peter Paul, Koek, Huiberdina L., OldeRikkert, Marcel G. M., Oleksik, Ania M., Richard, Edo, Smits, Lieke L., van Swieten, John C., Teune, Laura K., van der Lugt, Aad, Barkhof, Frederik, Teunissen, Charlotte E., Rozendaal, Nico, Verhey, Frans R. J., and van der Flier, Wiesje M.
- Subjects
NEURODEGENERATION ,DEGENERATION (Pathology) ,BRAIN degeneration ,BIOMATERIALS ,CHRONIC disease diagnosis ,GENETICS ,DIAGNOSIS - Abstract
Background The Parelsnoer Institute is a collaboration between 8 Dutch University Medical Centers in which clinical data and biomaterials from patients suffering from chronic diseases (so called □ Pearls□ ) are collected according to harmonized protocols. The Pearl Neurodegenerative Diseases focuses on the role of biomarkers in the early diagnosis, differential diagnosis and in monitoring the course of neurodegenerative diseases, in particular Alzheimer□ s disease . The objective of this paper is to describe the design and methods of the Pearl Neurodegenerative Diseases, as well as baseline descriptive variables, including their biomarker profile. Methods The Pearl Neurodegenerative Diseases is a 3-year follow-up study of patients referred to a memory clinic with cognitive complaints. At baseline, all patients are subjected to a standardized examination, including clinical data and biobank materials, e.g. blood samples, MRI and cerebrospinal fluid. Results At present, in total more than 1000 patients have been included, of which cerebrospinal fluid and DNA samples are available of 211 and 661 patients, respectively. First descriptives of a subsample of the data (n = 665) shows that patients are diagnosed with dementia (45%), mild cognitive impairment (31%), and subjective memory complaints (24%). Discussion The Pearl Neurodegenerative Diseases is an ongoing large network collecting clinical data and biomaterials of more than 1000 patients with cognitive impairments. The project has started with data analyses of the baseline characteristics and biomarkers, which will be the starting point of future specific research questions that can be answered by this unique dataset. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
6. Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment.
- Author
-
Kloppenborg, Raoul P., Richard, Edo, Sprengers, Marieke E. S., Troost, Dirk, Eikelenboom, Piet, and Nederkoorn, Paul J.
- Subjects
- *
AMYLOID , *BLOOD vessels , *HEPATIC encephalopathy , *INFLAMMATION , *IMMUNOSUPPRESSIVE agents - Abstract
Cerebral amyloid angiopathy (CAA) is a common but often asymptomatic disease, characterized by deposition of amyloid in cerebral blood vessels. We describe the successful treatment of CAA encephalopathy with dexamethasone in a patient with CAA-related inflammation causing subacute progressive encephalopathy and seizures, which is an increasingly recognized subtype of CAA. The two pathological subtypes of CAA-related inflammation are described and a review of the literature is performed concerning immunosuppressive treatment of CAA-related inflammation with special attention to its pathological subtypes. Immunosuppressive therapy appears to be an appropriate treatment for CAA encephalopathy. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.